HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Israël-Biet, D Articles by Cadranel, J Search for Related Content PubMed PubMed Citation Articles by Israël-Biet, D Articles by Cadranel, J

Impairment of ß chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia

¹ Laboratoire d’Immunopathologie Pulmonaire, UPRES EA220, Université Paris V, Paris, France
² Service de Pneumologie, Hôpital Européen Georges Pompidou, Paris, France
³ Service de Pneumologie et de Réanimation respiratoire, Hôpital Tenon, Paris, France

Correspondence to:
Correspondence to:
Professor D Israël-Biet
Service de Pneumologie, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France; dib.laennec{at}invivo.edu

Background: Pneumocystis jerovici pneumonia (PJP) remains a frequent opportunistic infection in HIV infected patients which markedly upregulates HIV replication by mechanisms so far poorly elucidated. PJP triggers the production of proinflammatory mediators with activating effects on HIV. However, anti-inflammatory factors with inhibiting effects on HIV are normally produced in parallel. We postulated that an imbalance of mediators normally controlling HIV replication could underlie its marked increase during PJP.

Methods: The production of tumour necrosis factor (TNF), interleukins IL-6 and IL-10, and ß-chemokine by bronchoalveolar lavage (BAL) cells recovered from HIV infected patients with and without PJP was compared. The pulmonary viral load was determined and correlations with cytokine and chemokine production were examined.

Results: TNF and IL-6 release was similar in patients with and without PJP but IL-10 and ß-chemokine release was markedly lower in the PJP group (IL-10: p<10^-2, RANTES, MIP-1 and MIP-1ß: p<0.001). The pulmonary viral load was markedly higher in patients with PJP (p<0.001) and correlated negatively with levels of MIP-1, RANTES and IL-10 in BAL fluid cells (p<0.05).

Conclusion: Pulmonary IL-10 and ß-chemokine production is markedly defective in HIV infected patients with PJP, while pulmonary TNF and IL-6 levels are normal. The resulting excess of these latter factors, which are known to upregulate HIV replication, might contribute to the increase in pulmonary viral load and to the more rapid HIV disease progression observed in patients with PJP.

Keywords: Pneumocystis jerovici pneumonia; HIV infection; cytokines; chemokines

Abbreviations: IL, interleukin; MIP, macrophage inflammatory protein; PJP, Pneumocystis jerovici pneumonia; RANTES, regulated on activation normal T cell expressed and secreted; TNF, tumour necrosis factor

This article has been cited by other articles:

				J. Cadranel and C. Mayaud Lung cancer in HIV infected patients Thorax, June 1, 2007; 62(6): 557 - 557. [Full Text] [PDF]